Therefore, in this study, we determined the predictive value of baseline patient characteristics (age, sex, and adiposity) extended with cardiometabolic comorbidities, leptin, and adiponectin in early (during treatment) and late (during aftercare) dropouts and short- and long-term treatment outcomes in children with obesity treated in an inpatient pediatric obesity treatment program. The gene discussed is LEP; the disease is obesity disorder.